Literature DB >> 16164833

T-Cell response profiling to biological threat agents including the SARS coronavirus.

C Gioia1, D Horejsh, C Agrati, F Martini, M R Capobianchi, G Ippolito, F Poccia.   

Abstract

The emergence of pathogens such as SARS and the increased threat of bioterrorism has stimulated the development of novel diagnostic assays for differential diagnosis. Rather than focusing on the detection of an individual pathogen component, we have developed a T cell profiling system to monitor responses to the pathogens in an array format. Using a matrix of antigens specific for different pathogens, a specific T cell profile was generated for each individual by monitoring the intracellular production of interferon-gamma by flow cytometry. This assay allows for the testing of multiple proteins or peptides at a single time and provides a quantitative and phenotypic assessment of CD4(+) and CD8(+) responding cells. We present profiling examples for several positive individuals, including those vaccinated with the smallpox and anthrax vaccines. We also show antigen optimization for the SARS-hCoV, as studies revealed that these proteins contain peptides which cross-react with more common coronaviruses, a cause of the common cold. The T cell array is an early and sensitive multiplex measure of active infection, exposure to a pathogen, or effective, recent vaccination.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16164833     DOI: 10.1177/039463200501800312

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  12 in total

1.  Distinct immunoregulatory cytokine pattern in Egyptian patients with occult Hepatitis C infection and unexplained persistently elevated liver transaminases.

Authors:  Yahia Z Gad; Narres Mouas; Azza Abdel-Aziz; Nashwa Abousmra; Mona Elhadidy
Journal:  Asian J Transfus Sci       Date:  2012-01

2.  Occupational transmission of an Orthopoxvirus infection during an outbreak in a colony of Macaca tonkeana in Lazio Region, Italy, 2015.

Authors:  V Puro; F M Fusco; C Castilletti; F Carletti; F Colavita; C Agrati; A Di Caro; M R Capobianchi; G Ippolito
Journal:  Zoonoses Public Health       Date:  2018-03-07       Impact factor: 2.702

Review 3.  Immunology of COVID-19: Current State of the Science.

Authors:  Nicolas Vabret; Graham J Britton; Conor Gruber; Samarth Hegde; Joel Kim; Maria Kuksin; Rachel Levantovsky; Louise Malle; Alvaro Moreira; Matthew D Park; Luisanna Pia; Emma Risson; Miriam Saffern; Bérengère Salomé; Myvizhi Esai Selvan; Matthew P Spindler; Jessica Tan; Verena van der Heide; Jill K Gregory; Konstantina Alexandropoulos; Nina Bhardwaj; Brian D Brown; Benjamin Greenbaum; Zeynep H Gümüş; Dirk Homann; Amir Horowitz; Alice O Kamphorst; Maria A Curotto de Lafaille; Saurabh Mehandru; Miriam Merad; Robert M Samstein
Journal:  Immunity       Date:  2020-05-06       Impact factor: 31.745

4.  Targeting the SARS-CoV2 nucleocapsid protein for potential therapeutics using immuno-informatics and structure-based drug discovery techniques.

Authors:  Alexander Kwarteng; Ebenezer Asiedu; Samuel Amoah Sakyi; Samuel Opoku Asiedu
Journal:  Biomed Pharmacother       Date:  2020-10-20       Impact factor: 6.529

5.  Immune response to SARS-CoV-2 in the nasal mucosa in children and adults.

Authors:  Clarissa M Koch; Andrew D Prigge; Kishore R Anekalla; Avani Shukla; Hanh Chi Do-Umehara; Leah Setar; Jairo Chavez; Hiam Abdala-Valencia; Yuliya Politanska; Nikolay S Markov; Grant R Hahn; Taylor Heald-Sargent; L Nelson Sanchez-Pinto; William J Muller; Alexander V Misharin; Karen M Ridge; Bria M Coates
Journal:  medRxiv       Date:  2021-01-28

Review 6.  The human coronaviruses (HCoVs) and the molecular mechanisms of SARS-CoV-2 infection.

Authors:  Luigi Santacroce; Ioannis A Charitos; Domenico M Carretta; Emanuele De Nitto; Roberto Lovero
Journal:  J Mol Med (Berl)       Date:  2020-12-02       Impact factor: 4.599

7.  Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia.

Authors:  Rogan A Grant; Luisa Morales-Nebreda; Nikolay S Markov; Suchitra Swaminathan; Melissa Querrey; Estefany R Guzman; Darryl A Abbott; Helen K Donnelly; Alvaro Donayre; Isaac A Goldberg; Zasu M Klug; Nicole Borkowski; Ziyan Lu; Hermon Kihshen; Yuliya Politanska; Lango Sichizya; Mengjia Kang; Ali Shilatifard; Chao Qi; Jon W Lomasney; A Christine Argento; Jacqueline M Kruser; Elizabeth S Malsin; Chiagozie O Pickens; Sean B Smith; James M Walter; Anna E Pawlowski; Daniel Schneider; Prasanth Nannapaneni; Hiam Abdala-Valencia; Ankit Bharat; Cara J Gottardi; G R Scott Budinger; Alexander V Misharin; Benjamin D Singer; Richard G Wunderink
Journal:  Nature       Date:  2021-01-11       Impact factor: 69.504

Review 8.  Distinctive features of severe SARS-CoV-2 pneumonia.

Authors:  G R Scott Budinger; Alexander V Misharin; Karen M Ridge; Benjamin D Singer; Richard G Wunderink
Journal:  J Clin Invest       Date:  2021-07-15       Impact factor: 19.456

9.  Cross-subtype immunity against avian influenza in persons recently vaccinated for influenza.

Authors:  Cristiana Gioia; Concetta Castilletti; Massimo Tempestilli; Paola Piacentini; Licia Bordi; Roberta Chiappini; Chiara Agrati; Salvatore Squarcione; Giuseppe Ippolito; Vincenzo Puro; Maria R Capobianchi; Fabrizio Poccia
Journal:  Emerg Infect Dis       Date:  2008-01       Impact factor: 6.883

10.  Anti-severe acute respiratory syndrome coronavirus immune responses: the role played by V gamma 9V delta 2 T cells.

Authors:  Fabrizio Poccia; Chiara Agrati; Concetta Castilletti; Licia Bordi; Cristiana Gioia; Douglas Horejsh; Giuseppe Ippolito; Paul K S Chan; David S C Hui; Joseph J Y Sung; Maria Rosaria Capobianchi; Miroslav Malkovsky
Journal:  J Infect Dis       Date:  2006-03-27       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.